The first international consensus statement on sarcoidosis is currently being copublished in
the journals of the American Thoracic Society (ATS) and the World Association for …

Sarcoidosis Sarcoidosis is a lung disease of unknown cause characterized by noncaseating
granulomas; the heart and nervous system may also be involved. It is often misdiagnosed; …

Sarcoidosis is a multisystem granulomatous disease with large variability in presentation,
disease behavior, and outcome. The cause of sarcoidosis and explanation for its wide …

Sarcoidosis is an idiopathic granulomatous disease. It usually affects the lung but may
involve any organ. The diagnosis may be problematic because known causes of …

The clinical expression, natural history, and prognosis of sarcoidosis are highly variable and
its course is often unpredictable. 1 Clinical manifestations vary with the organs involved. 1, 2 …

Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on …

Over the past few years an increasing number of prospective controlled sarcoidosis
treatment trials have been completed. Unfortunately, these studies utilize different endpoints …

Sarcoidosis is a systemic granulomatous inflammatory disease of unknown etiology. It
affects the lungs in over 90% of patients yet extra-pulmonary and multi-organ involvement is …

This is an update on sarcoidosis, focusing on etiology, diagnosis, and treatment. In the area
of etiopathogenesis, we now have a better understanding of the immune response that …

The focus of this review is current knowledge about the epidemiology, clinical
manifestations, diagnosis, and treatment of both pulmonary sarcoidosis and extrapulmonary …